Diskin; Ron

Patent Applications and Registrations

Patent applications and USPTO patent grants for Diskin; Ron.The latest application filed is for "antibodies targeting hiv escape mutants".

Company Profile

3.9.12

Diskin; Ron - Pasadena CA
Diskin; Ron - Rehovot IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies Targeting Hiv Escape Mutants App 20220169707 - Diskin; Ron ; et al.	2022-06-02
HIV-1 GP120 CD4 binding site antibodies targeting HIV escape mutants Grant 11,149,081 - Diskin , et al. October 19, 2	2021-10-19
Human Immunodeficiency Virus Neutralizing Antibodies And Methods Of Use Thereof App 20210230254 - Scheid; Johannes ; et al.	2021-07-29
Human immunodeficiency virus neutralizing antibodies and methods of use thereof Grant 10,889,633 - Scheid , et al. January 12, 2	2021-01-12
Immunotherapy Against Transferrin Receptor 1 (tfr1)-tropic Arenaviruses App 20200392203 - DISKIN; Ron ; et al.	2020-12-17
Highly Active Agonistic Cd4 Binding Site Anti-hiv Antibodies (haads) Comprising Modified Cdrh2 Regions That Improve Contact With App 20200165325 - Diskin; Ron ; et al.	2020-05-28
Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with gp120 Grant 10,590,187 - Diskin , et al.	2020-03-17
Highly Active Agonistic Cd4 Binding Site Anti-hiv Antibodies (haads) Comprising Modified Cdrh2 Regions That Improve Contact With Gp120 App 20180237506 - Diskin; Ron ; et al.	2018-08-23
Antibodies Targeting Hiv Escape Mutants App 20180230203 - Diskin; Ron ; et al.	2018-08-16
Human Immunodeficiency Virus Neutralizing Antibodies and Methods of Use Thereof App 20180079800 - Scheid; Johannes ; et al.	2018-03-22
Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 Grant 9,890,207 - Diskin , et al. February 13, 2	2018-02-13
Antibodies targeting HIV escape mutants Grant 9,879,068 - Diskin , et al. January 30, 2	2018-01-30
Human immunodeficiency virus neutralizing antibodies and methods of use thereof Grant 9,783,594 - Scheid , et al. October 10, 2	2017-10-10
Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth Grant 9,493,549 - Diskin , et al. November 15, 2	2016-11-15
Human Immunodeficiency Virus Neutralizing Antibodies And Methods Of Use Thereof App 20140328862 - Scheid; Johannes ; et al.	2014-11-06
Antibodies Targeting Hiv Escape Mutants App 20140017234 - Diskin; Ron ; et al.	2014-01-16
Anti-hiv Antibodies Having Increased Potency And Breadth App 20130209454 - Diskin; Ron ; et al.	2013-08-15
Compositions And Methods For Improving Potency And Breadth Of Hiv Antibodies App 20120288502 - Diskin; Ron ; et al.	2012-11-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.